No upcoming workshops & webinars this month
Baheya research center was established in 2017. It has conducted over 250 research studies, 60 of them published in prestigious scientific journals. These studies have contributed to doctoral and master’s thesis and graduation projects
The Center's Scientific and Ethical Review Committee adheres to the Helsinki Declaration, the Islamic Organization for Medical Sciences, the US Office for Human Research Protection, and the US Federal Regulations, complying with FWA number (FWA) FWA00030390 and IRB00012829.
Baheya Research Center focuses on a wide range of topics related to breast cancer:
One of Baheya’s Research Center strategic objectives is to achieve tangible results on the ground by establishing a strong research infrastructure that includes:
Overall, Baheya Research Center plays a vital role in advancing the understanding and treatment of breast cancer. Through its rigorous research and collaborations, the center is making a significant contribution to improving the lives of women around the world.
Established in 2017, Baheya Research Center stands as a beacon of hope in the global fight against breast cancer. Its mission is clear: to actively participate in the eradication of this disease by identifying its root causes and developing innovative research strategies for prevention, diagnosis, and treatment.
Since its inception, the center has embarked on an impressive journey, conducting over 240 studies encompassing research projects, doctoral and master's theses, and graduation projects. Their unwavering commitment to scientific rigor has resulted in the publication of 55 groundbreaking research papers in esteemed scientific journals.
Rigorous ethical standards are paramount at Baheya Research Center. Every research endeavor undergoes meticulous scientific and ethical review, ensuring that the highest standards are upheld. Only after receiving IRB approval does research commence, guaranteeing the well-being of participants and the integrity of the research process.
The center's unwavering mission is to play a pivotal role in the global battle against breast cancer. By delving into the underlying causes and risk factors of the disease, they strive to develop innovative research strategies that will revolutionize prevention, diagnosis, treatment, and ultimately, the eradication of breast cancer.
Their vision is to establish Baheya Research Center as a regional and international center of excellence in breast cancer research, making significant contributions to addressing this global health challenge. With unwavering dedication and a commitment to scientific excellence, Baheya Research Center is poised to make a lasting impact on the lives of millions affected by breast cancer worldwide.
Our mission is to take part in the global fight against breast cancer through identifying causes and develop innovative research strategies for prevention, diagnosis, treatment, and cure of breast cancer
Our vision is to be a center of excellence in breast cancer research at the regional and international level by contributing in solving the problems of breast cancer worldwide.
No upcoming workshops & webinars this month
No upcoming workshops & webinars this month
Baheya Foundation puts emphasis on the well-being of the fighters and its employees but also their families. Baheya has celebrated the fighter and employees’ daughters and sons who have just graduated from Thanwaya Amma with excellency.
Nassar, A., Zekri, A. R. N., Kamel, M. M., Elberry, M. H., Lotfy, M. M., Seadawy, M. G., ... & Youssef, A. S. E. D. (2022). Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study. Genes, 14(1), 106.
Abd El Wahab, M. H., Ibrahim, A. H., Gado, O., Bahbah, A. M., Fadlalla, W., Fakhry, S., ... & Helal, A. M. (2023). Changes in breast cancer staging trends among Egyptian women after COVID-19: A retrospective single-center study. International Journal of Immunopathology and Pharmacology, 37, 03946320231152835.
Kamel, S. M., Abdel Azeem, M. E., Mohamed, R. A., Kamel, M. M., & Abdel Aleem, E. A. (2023). High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus. International Journal of Immunopathology and Pharmacology, 37,03946320231154988.
Azmy, O., El Shebini, S. M., Ahmed, N. H., Abu-Elghait, M., Gomaa, M. M. M., Goda, A. A., ... & Mahmoud, W. S. (2023). Assessment of Macronutrients dietary intake, central adiposity among pre-and postmenopausal Egyptian women with benign and malignant breast tumors. Clinical Nutrition ESPEN.
Mahmoud, W. S., Azmy, O. M., Abu-Elghait, M., Gomaa, M. M. M., El Sayed, I. E. T., Hammad, D. Y., ... & Yousef, W. (2022). Metabolic syndrome as independent risk factor among sample of Egyptian women with breast cancer. Bulletin of the National Research Centre, 46(1), 1-9.
Jailin, C., De Carvalho, P. M., Mohamed, S., Vancamberg, L., Ibrahim, M. A. F., Gomaa, M. M., ... & Muller, S. (2023). Deformable registration with intensity correction for CESM monitoring response to Neoadjuvant Chemotherapy. Biomedical Physics & Engineering Express, 9(3), 035003.
Al-Najar, K. M., Ibraheem, M. H., Zaki, R. M., Mohamed, D. A., Hady, A. A. A. A., & EL-Nahas, N. G. (2022). Effect of respiratory muscle training on ventilatory function in women post mastectomy. International Journal of Health Sciences, 6(S9), 3205–3213.
Amin, M. N., Kamal, R., Farouk, A., Gomaa, M., Rushdi, M. A., & Mahmoud, A. M. (2023). An efficient hybrid computer-aided breast cancer diagnosis system with wavelet packet transform and synthetically-generated contrast-enhanced spectral mammography images. Biomedical Signal Processing and Control, 85, 104808.
Hussein, S.A., EL-Dhurani, S., Abdelnaby, Y. et al. High-risk breast lesions: role of multi-parametric DCE-MRI in detection and histopathological upgrade prediction. Egypt J Radiol Nucl Med 53, 212 (2022).
Rahman, R. W. A., Al-Dhurani, S. Y. A., Radwan, A. H., Mohamed, A. A., & Kamal, E. F. (2022). Multi-detector CT chest: can it omit the further need for contrast enhnaced spectral mammography in breast cancer patients candidate for CT staging? Egyptian Journal of Radiology and Nuclear Medicine, 53(1), 1-8.
Kamal, R. M., Mostafa, S., Salem, D., ElHatw, A. M., Mokhtar, S. M., Wessam, R., & Fakhry, S. (2022). Body mass index, breast density, and the risk of breast cancer development in relation to the menopausal status; results from a population-based screening program in a native African-Arab country. Acta Radiologica Open, 11(6), 20584601221111704.
Fakhry, S., Kamal, R. M., Tohamey, Y. M., & Kamal, E. F. (2022). Unilateral primary breast edema: Can T2-weighted images meet the diagnostic challenge?. Egyptian Journal of Radiology and Nuclear Medicine, 53(1), 1-11.
Mansour, S., Hamed, S., & Kamal, R. (2022). Incidental Ovarian Lesions. The British Journal of Radiology, 20211325.
Fakhry, S., Abdel Rahman, R. W., Shaalan, H. S., Hassan, M. H. I., Tealab, S. H., & Sayed, S. B. (2022). The added role of contrast-enhanced spectral mammography in the evaluation of pathological nipple discharge. Egyptian Journal of Radiology and Nuclear Medicine, 53(1), 1-10.
Fathalla, L. A., Kamal, L. M., Salaheldin, O., Khalil, M. A., Kamel, M. M., Fahim, H. H., ... & El-Meligui, Y. M. (2022). Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients. International Journal of Immunopathology and Pharmacology, 36, 03946320221096207.
Mansour, S., Soliman, S., Kansakar, A., Marey, A., Hunold, C., & Hanafy, M. (2022). Strengths and challenges of the artificial intelligence in the assessment of dense breasts. BJR| Open, (1), 20220018.
Hussein, Samar Ahmed, et al. "High-risk breast lesions: role of multi-parametric DCE-MRI in detection and histopathological upgrade prediction." Egyptian Journal of Radiology and Nuclear Medicine 53.1 (2022): 1-12.
Elmahs, A., Mohamed, G., Salem, M., Omar, D., Helal, A., & Soliman, N. (2022). The Impact of Tumor Infiltrating Lymphocytes Densities and Ki67 Index on Residual Breast Cancer Burden following Neoadjuvant Chemotherapy. International journal of breast cancer, 2022.
Ahmed, O. S. M., Youssef, L., Moaz, I., Aboali, S. E. M., & Roshdy, S. H. A. (2022). Evaluation And Re-Evaluation Of Post-Mastectomy Pain Syndrome By Breast Cancer Edge Task Force Outcomes: Clinical Measures Of Pain After Pain Management Protocol Of Physiotherapy. Journal of Pharmaceutical Negative Results, 1243-1254.
El-Toukhy, S.E., El-Daly, S.M., Kamel, M.M. et al. The diagnostic significance of circulating miRNAs and metabolite profiling in early prediction of breast cancer in Egyptian women. J Cancer Res Clin Oncol (2022).
Mahmoud, W. S., Azmy, O. M., Abu-Elghait, M., Gomaa, M. M. M., El Sayed, I. E. T., Hammad, D. Y., ... & Yousef, W. (2022). Metabolic syndrome as independent risk factor among sample of Egyptian women with breast cancer. Bulletin of the National Research Centre, 46(1), 1-9.
Mohamed, G., El-Tohamy, M., Yousri, M., & Gomaa, M.M. (2021). Breast augmentation complications following polyacrylamide hydrogel injection and fat grafting: Clinicopathologic report of 2 cases. Journal of Histology and Histopathology.
Fahim HH, Mohamed G, Safwat G, Abo-Bakr A, Ibraheem MH, Al-Mofty S, Kamel MM, Abdel-Moneim AS, Gameel AM. HSP70 as a Diagnostic and Prognostic Marker in Egyptian Women with Breast Cancer. Clin Breast Cancer. 2021 Jun;21(3):e177-e188. Epub 2020 Nov 13. PMID: 33323333.
COVIDSurg Collaborative; GlobalSurg Collaborative. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 2021 Jun;76(6):748-758. doi: 10.1111/anae.15458. Epub 2021 Mar 9. PMID: 33690889; PMCID: PMC8206995.
COVIDSurg Collaborative, GlobalSurg Collaborative. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international perspective cohort study. Br J Surg. 2021 Sep 27;108 (9):1056-1063. PMID: 33761533;PMCID:PMC7995808.
COVIDSurg Collaborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol. 2021 Nov;22 (11):1507-1517. doi: 10.1016/S1470-2045(21)00493-9. Epub 2021 Oct 5. PMID: 34624250; PMCID: PMC8492020.
Kamal, R., Mansour, S., Farouk, A. et al. Contrast-enhanced mammography in comparison with dynamic contrast-enhanced MRI: which modality is appropriate for whom? Egypt J Radiol Nucl Med 52, 216 (2021).
Abdel Rahman, R.W., Refaie, R.M.A.E., Kamal, R.M. et al. The diagnostic accuracy of diffusion-weighted magnetic resonance imaging and shear wave elastography in comparison to dynamic contrast-enhanced MRI for diagnosing BIRADS 3 and 4 lesions. Egypt J Radiol Nucl Med 52, 185 (2021).
Shetat, O.M.M., Moustafa, A.F.I., Zaitoon, S. et al. Added value of contrast-enhanced spectral mammogram in assessment of suspicious microcalcification and grading of DCIS. Egypt J Radiol Nucl Med 52, 186 (2021).
COVIDSurg Collaborative. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score. Br J Surg. 2021 Nov 11;108(11):1274-1292. doi: 10.1093/bjs/znab183. PMID: 34227657; PMCID: PMC8344569.
Shen Y, Shamout FE, Oliver JR, Witowski J, et al. Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams. Nat Commun. 2021 Sep 24;12(1):5645.PMID:34561440; PMCID: PMC8463596.
Hafez, A., Abdelaziz, D. M., Khalil, M. M., & El-Nagdy, M. S. (2021). Quantifying inter-and intra-fraction variations of breast cancer radiotherapy with skin dose measurements. Biomedical physics & engineering express, 7(4), 045026.
Mohamed,G, El-Tohamy,M., Yousri,M., & Gomaa,M.M. (2021). Breast augmentation complications following polyacrylamide hydrogel injection and fat grafting: Clinicopathologic report of 2 cases. Journal of Histology & Histopathology, 8(5) ISSN 2055-091X.
Hafez, A., Abdelaziz, D. M., Khalil, M. M., & El-Nagdy, M. S. (2020). The necessity of using deep inspiration breath-hold in the radiotherapy of left breast cancer patients who undergo the UK FAST trial. Biomedical Physics & Engineering Express, 7(1), 015004.
Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study
More Details
|
View Link
The Baheya EC is organized and operated according to guidelines of Helsinki deceleration and the Islamic Organization for Medical Sciences (IOMS), the United States Office for Human Research Protections and the United States Code of Federal Regulations and operates under Federal Wide Assurance (FWA) No. FWA00030390 and IRB00012829.
 1.png)
Arabic & English protocol, (1 copy)
Arabic & English informed consent, (1 copy)
Pharmaceutical Company: A valid insurance policy till the end of the project or for at least one year
The Principle Investigator (PI) CV, (1 copy)
Filling the Form Investigator Application
The first three requirements to be sent electronically
Reviewing Process: Reviewing process consumes one to three months, before acquiring the approval certificate valid for one year
9:00 AM ~ 5:00 PM
16602
4, Allouba St. off El Haram St. Next to Dary, Giza - Egypt
